logo

For the Inventor, By the Inventor

Wynnewood, PA, United States of America

Hank F Kung

USPTO Granted Patents = 39 

 

 

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 269(Granted Patents)


Location History:

  • Winnewood, PA (US) (2010)
  • Wynnewood, PA (US) (1990 - 2013)
  • Springfield, PA (US) (2013 - 2021)

Company Filing History:

goldMedal34 out of 2,623 
 
University of Pennsylvania
 patents
silverMedal4 out of 4 
 
Five Eleven Pharma Inc.
 patents
bronzeMedal1 out of 3,390 
 
University of Michigan
 patents
4. 1 out of 2 
 
Avid Radiopharmaceuticals, Inc.
 patents
5. 1 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2021

Loading Chart...
Loading Chart...
Loading Chart...
39 patents (USPTO):Explore Patents
1. 11071794 - Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application (2021-07-27),
2. 10912849 - Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application (2021-02-09),
3. 10688200 - Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy (2020-06-23),
4. 10253052 - HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents (2019-04-09),
5. 8840866 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2014-09-23),
6. 8747809 - Single diastereomers of 4-fluoroglutamine and methods of their preparation and use (2014-06-10),
7. 8562949 - Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents (2013-10-22),
8. 8506929 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2013-08-13),
9. RE44354 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-08),
10. RE44338 - Amyloid plaque aggregation inhibitors and diagnostic imaging agents (2013-07-01),
11. 8465726 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2013-06-18),
12. 7858072 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-12-28),
13. 7807135 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-10-05),
14. 7759502 - Stilbene derivatives and their use for binding and imaging amyloid plaques (2010-07-20),
15. 7687052 - Styrylpyridine derivatives and their use for binding and imaging amyloid plaques (2010-03-30),

Title: Inventor Spotlight: Hank F Kung - Revolutionizing PET Imaging

Introduction:

Hank F Kung, a prolific inventor hailing from Wynnewood, PA, has left an indelible mark in the field of medical imaging with his groundbreaking work in deuterium-substituted positron emission tomography (PET) imaging agents. With an impressive portfolio of 39 patents to his name, Kung is a true innovator in the realm of neuroscience and pharmaceuticals.

Latest Patents:

Kung's latest patents showcase his expertise in developing deuterium-substituted compounds for PET imaging applications. These compounds, outlined in Formula I-A, Formula II-A, Formula II-D, and Formula III-A, have proven instrumental in evaluating conditions such as Parkinson's Disease, Alzheimer's Disease, and in assessing specific serotonin reuptake inhibitor (SSRI) activity for treating depression. His pharmaceutical compositions, incorporating these compounds, have opened new avenues for precision medicine.

Career Highlights:

Throughout his illustrious career, Kung has made significant contributions while working with esteemed institutions such as the University of Pennsylvania and Five Eleven Pharma Inc. His dedication to advancing medical imaging technologies has garnered him recognition as a trailblazer in the field, shaping the future of diagnostic techniques.

Collaborations:

Kung's collaborative spirit is evidenced by his partnerships with esteemed colleagues Mei-Ping Kung and Zhi-Ping Zhuang. Together, they have synergized their expertise to push the boundaries of PET imaging, driving innovation and enhancing patient care.

Conclusion:

In conclusion, Hank F Kung stands as a luminary in the field of PET imaging, with a rich tapestry of patents and innovations that have redefined diagnostic practices. His relentless pursuit of excellence and commitment to advancing healthcare technologies continue to inspire the next generation of inventors and researchers in the quest for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…